These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 36403054

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.
    Pragman AA, Knutson KA, Gould TJ, Hodgson SW, Isaacson RE, Reilly CS, Wendt CH.
    PLoS One; 2019; 14(7):e0219962. PubMed ID: 31335912
    [Abstract] [Full Text] [Related]

  • 6. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
    Pragman AA, Knutson KA, Gould TJ, Isaacson RE, Reilly CS, Wendt CH.
    Respir Res; 2019 Jun 07; 20(1):114. PubMed ID: 31174538
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
    Su L, Qiao Y, Luo J, Huang R, Li Z, Zhang H, Zhao H, Wang J, Xiao Y.
    J Transl Med; 2022 Feb 05; 20(1):76. PubMed ID: 35123490
    [Abstract] [Full Text] [Related]

  • 10. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort.
    Bouquet J, Tabor DE, Silver JS, Nair V, Tovchigrechko A, Griffin MP, Esser MT, Sellman BR, Jin H.
    Respir Res; 2020 Mar 30; 21(1):77. PubMed ID: 32228581
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability.
    Dang X, Kang Y, Wang X, Cao W, Li M, He Y, Pan X, Ye K, Xu D.
    Front Microbiol; 2022 Mar 30; 13():1037037. PubMed ID: 36532417
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exploring the microbiota difference of bronchoalveolar lavage fluid between community-acquired pneumonia with or without COPD based on metagenomic sequencing: a retrospective study.
    Wang B, Tan M, Li W, Xu Q, Jin L, Xie S, Wang C.
    BMC Pulm Med; 2024 Jun 12; 24(1):278. PubMed ID: 38867204
    [Abstract] [Full Text] [Related]

  • 18. Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations.
    Xiao W, Chen YL, Du LY, Wu J, Wang Z, Mao B, Wen FQ, Gibson PG, McDonald VM, Yu H, Fu JJ.
    Respir Res; 2024 Apr 20; 25(1):173. PubMed ID: 38643126
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z, Maschera B, Lea S, Kolsum U, Michalovich D, Van Horn S, Traini C, Brown JR, Hessel EM, Singh D.
    Respir Res; 2019 Jun 06; 20(1):113. PubMed ID: 31170986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.